We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPC
5676
CALL
Tutor Perini Cor
TPC
$4.41B
$22K ﹤0.01%
700
LUMO
5677
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$22K ﹤0.01%
100
-1,467
-94% -$210K
MGP
5678
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$22K ﹤0.01%
809
-11
-1% -$282
SMRT
5679
DELISTED
Stein Mart Inc
SMRT
$22K ﹤0.01%
7,602
+6,589
+650% +$23.3K
STML
5680
DELISTED
Stemline Therapeutics, Inc.
STML
$22K ﹤0.01%
2,592
+957
+59% +$8.72K
EGN
5681
PUT
DELISTED
Energen
EGN
$22K ﹤0.01%
400
+100
+33% +$5.41K
ENTL
5682
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$22K ﹤0.01%
1,589
+1,272
+401% +$20.4K
SCLN
5683
CALL
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$22K ﹤0.01%
2,200
-11,800
-84% -$118K
WMAR
5684
DELISTED
West Marine Inc
WMAR
$22K ﹤0.01%
2,293
+2,044
+821% +$19.3K
LUX
5685
DELISTED
Luxottica Group
LUX
$22K ﹤0.01%
+400
New +$21.4K
VAL
5686
PUT
DELISTED
Valspar
VAL
$22K ﹤0.01%
+200
New +$22K
ALTO icon
5687
PUT
Alto Ingredients
ALTO
$369M
$21K ﹤0.01%
3,000
-14,400
-83% -$110K
CVSA
5688
PUT
Covista Inc
CVSA
$4.25B
$21K ﹤0.01%
600
-4,300
-88% -$142K
BRKL
5689
DELISTED
Brookline Bancorp
BRKL
$21K ﹤0.01%
1,312
-979
-43% -$15.4K
EXTR icon
5690
Extreme Networks
EXTR
$3.94B
$21K ﹤0.01%
2,830
-189,240
-99% -$1.13M
FLO icon
5691
PUT
Flowers Foods
FLO
$1.49B
$21K ﹤0.01%
1,100
-96,000
-99% -$1.89M
GERN icon
5692
PUT
Geron
GERN
$828M
$21K ﹤0.01%
9,400
-13,600
-59% -$29K
TRUP icon
5693
Trupanion
TRUP
$1.07B
$21K ﹤0.01%
1,506
+1,013
+205% +$15.5K
UHT
5694
Universal Health Realty Income Trust
UHT
$603M
$21K ﹤0.01%
316
-294
-48% -$18.6K
XES icon
5695
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$374M
$21K ﹤0.01%
107
-280
-72% -$60.6K
XIN
5696
DELISTED
Xinyuan Real Estate
XIN
$21K ﹤0.01%
476
+471
+9,420% +$23.6K
VJET
5697
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$21K ﹤0.01%
1,570
ATCO
5698
CALL
DELISTED
Atlas Corp.
ATCO
$21K ﹤0.01%
3,000
+2,900
+2,900% +$24K
VIVO
5699
DELISTED
Meridian Bioscience Inc
VIVO
$21K ﹤0.01%
1,523
-1,201
-44% -$16.8K
DERM
5700
DELISTED
Dermira, Inc.
DERM
$21K ﹤0.01%
597
-71,335
-99% -$2.3M

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.